Overview

Study to Evaluate the Pharmacokinetics and Safety of INX-08189 Administered With VictrelisTM in Healthy Subjects

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the potential for a pharmacokinetic drug-drug interaction between INX-08189 and Victrelis, a Direct Acting Antiviral (DAA).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb